Proteostasis and Ribostasis Impairment as Common Cell Death Mechanisms in Neurodegenerative Diseases

被引:6
|
作者
Lim, Su Min [1 ,2 ]
Nahm, Minyeop [3 ]
Kim, Seung Hyun [1 ,2 ,4 ,5 ]
机构
[1] Hanyang Univ, Coll Med, Cell Therapy Ctr, Seoul, South Korea
[2] Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea
[3] Korea Brain Res Inst, Dementia Res Grp, Daegu, South Korea
[4] Hanyang Univ, Coll Med, Cell Therapy Ctr, 222 Wangsimni Ro, Seoul, South Korea
[5] Hanyang Univ, Coll Med, Dept Neurol, 222 Wangsimni Ro, Seoul, South Korea
来源
JOURNAL OF CLINICAL NEUROLOGY | 2023年 / 19卷 / 02期
基金
新加坡国家研究基金会;
关键词
proteostasis; ribostasis; neurodegenerative disease; liquid-liquid phase separation; cell death mechanism; FRONTOTEMPORAL LOBAR DEGENERATION; ALPHA-SYNUCLEIN AGGREGATION; RNA-BINDING PROTEINS; SUPEROXIDE-DISMUTASE; MESSENGER-RNA; LEWY BODY; MOLECULAR CHAPERONES; ALZHEIMER-DISEASE; PHASE-SEPARATION; MOUSE MODEL;
D O I
10.3988/jcn.2022.0379
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The cellular homeostasis of proteins (proteostasis) and RNA metabolism (ribostasis) are es-sential for maintaining both the structure and function of the brain. However, aging, cellular stress conditions, and genetic contributions cause disturbances in proteostasis and ribostasis that lead to protein misfolding, insoluble aggregate deposition, and abnormal ribonucleopro-tein granule dynamics. In addition to neurons being primarily postmitotic, nondividing cells, they are more susceptible to the persistent accumulation of abnormal aggregates. Indeed, de-fects associated with the failure to maintain proteostasis and ribostasis are common patho-genic components of age-related neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Furthermore, the neuronal deposition of misfolded and aggregated proteins can cause both increased toxicity and impaired physio-logical function, which lead to neuronal dysfunction and cell death. There is recent evidence that irreversible liquid-liquid phase separation (LLPS) is responsible for the pathogenic ag-gregate formation of disease-related proteins, including tau, alpha-synuclein, and RNA-binding proteins, including transactive response DNA-binding protein 43, fused in sarcoma, and het-erogeneous nuclear ribonucleoprotein A1. Investigations of LLPS and its control therefore sug-gest that chaperone/disaggregase, which reverse protein aggregation, are valuable therapeutic targets for effective treatments for neurological diseases. Here we review and discuss recent studies to highlight the importance of understanding the common cell death mechanisms of and ribostasis in diseases.
引用
收藏
页码:101 / 114
页数:14
相关论文
共 50 条
  • [21] Apoptotic cell death in neuroinflammatory and neurodegenerative diseases
    Gold, R
    Stadelmann, C
    Brück, W
    Lassmann, H
    AKTUELLE NEUROLOGIE, 2001, 28 (01) : 17 - 25
  • [22] Neurodegenerative diseases and cancer: sharing common mechanisms in complex interactions
    Gonzalez Rojas, Natalia
    Cesarini, Martin
    Luis Etcheverry, Jose
    Andres Da Prat, Gustavo
    Antico Arciuch, Valeria
    Mabel Gatto, Emilia
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2020, 19 (01) : 187 - 199
  • [23] Depression in neurodegenerative diseases: Common mechanisms and current treatment options
    Galts, Ciaran P. C.
    Bettio, Luis E. B.
    Jewett, David C.
    Yang, Charles C.
    Brocardo, Patricia S.
    Rodrigues, Ana Lucia S.
    Thacker, Jonathan S.
    Gil-Mohapel, Joana
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2019, 102 : 56 - 84
  • [24] Neurons and mechanisms of neuronal death in neurodegenerative diseases: A brief review
    Waggie, KS
    Kahle, PJ
    Tolwani, RJ
    LABORATORY ANIMAL SCIENCE, 1999, 49 (04): : 358 - 362
  • [25] Improper Proteostasis: Can It Serve as Biomarkers for Neurodegenerative Diseases?
    Ankur Rakesh Dubey
    Som Mohanlal Patwa
    Sumit Kinger
    Yuvraj Anandrao Jagtap
    Prashant Kumar
    Sarika Singh
    Rohan Dhiman
    Hem Chandra Jha
    Amit Mishra
    Molecular Neurobiology, 2022, 59 : 3382 - 3401
  • [26] Improper Proteostasis: Can It Serve as Biomarkers for Neurodegenerative Diseases?
    Dubey, Ankur Rakesh
    Patwa, Som Mohanlal
    Kinger, Sumit
    Jagtap, Yuvraj Anandrao
    Kumar, Prashant
    Singh, Sarika
    Dhiman, Rohan
    Jha, Hem Chandra
    Mishra, Amit
    MOLECULAR NEUROBIOLOGY, 2022, 59 (06) : 3382 - 3401
  • [27] Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
    Hoehn, Annika
    Tramutola, Antonella
    Cascella, Roberta
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [28] Relationship of proteostasis and nucleocytoplasmic transport in neurodegenerative diseases.
    Zhang, K.
    Cunningham, K.
    Ruan, K.
    Grima, J.
    Daigle, G.
    Rothstein, J.
    Lloyd, T. E.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [29] TRIM family proteins: roles in proteostasis and neurodegenerative diseases
    Zhu, Yan
    Afolabi, Lukman O.
    Wan, Xiaochun
    Shim, Joong Sup
    Chen, Liang
    OPEN BIOLOGY, 2022, 12 (08)
  • [30] TSPO AND CELL DEATH IMPLICATIONS FOR CANCER AND NEURODEGENERATIVE DISEASES
    Gavish, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 10 - 10